Research Solutions, Inc. (RSSS)
| Market Cap | 72.24M -22.5% |
| Revenue (ttm) | 48.66M -0.2% |
| Net Income | 4.52M |
| EPS | 0.14 |
| Shares Out | 32.39M |
| PE Ratio | 15.53 |
| Forward PE | 14.87 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 22,586 |
| Open | 2.290 |
| Previous Close | 2.305 |
| Day's Range | 2.220 - 2.300 |
| 52-Week Range | 2.000 - 4.120 |
| Beta | 0.75 |
| Analysts | Buy |
| Price Target | 3.83 (+71.75%) |
| Earnings Date | Sep 17, 2026 |
About RSSS
Research Solutions, Inc., through its subsidiaries, provides research cloud-based software-as-a-service software platform and related services to corporate, academic, government and individual researchers in the United States, Europe, and internationally. It provides Discover Tools that facilitates search discovery across virtually all scientific, technical, and medical (STM) articles available, including basic search solutions and advanced search tools comprising Resolute.ai and Scite.ai products, a tools that allows for searching and identify... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 2 analysts, the average rating for RSSS stock is "Buy." The 12-month stock price target is $3.83, which is an increase of 71.75% from the latest price.
News
Research Solutions to Participate at Upcoming Investor Conferences
HENDERSON, Nev., Aug. 18, 2026 /PRNewswire/ -- Research Solutions (RSSS) today announced management will participate at the following investor conferences: Midwest IDEAS Conference August 27Location: ...
Research Solutions Transcript: 16th Annual East Coast IDEAS Conference
The company leverages proprietary agreements with major publishers to deliver research access and analytics through AI-integrated tools, serving a broad customer base. Its scalable platform business drives high margins and growth, while evolving publisher partnerships open new revenue streams.
Element Biosciences Announces Upsized Series E to Accelerate Global Growth Across Ecosystem of Genomic, Multiomic, and Clinical Research Solutions
SAN DIEGO--(BUSINESS WIRE)--Element Biosciences, Inc. today announced an upsized Series E round of financing, including $175 million from longstanding investor Samsung Electronics, and an undisclosed ...
Research Solutions to Present and Host 1x1 Investor Meetings at the 16th Annual East Coast IDEAS Investor Conference on June 10th in New York, NY
HENDERSON, Nev., June 4, 2026 /PRNewswire/ -- Research Solutions (RSSS), today announced management will present at the East Coast IDEAS Investor Conference on Wednesday June 10 , 2026 at The Westin T...
Research Solutions price target lowered to $4 from $5 at Lake Street
Lake Street analyst Jacob Stephan lowered the firm’s price target on Research Solutions (RSSS) to $4 from $5 and keeps a Buy rating on the shares. Q3 results were “mixed,”…
Research Solutions price target lowered to $3.50 from $5 at Roth Capital
Roth Capital analyst Richard Baldry lowered the firm’s price target on Research Solutions (RSSS) to $3.50 from $5 and keeps a Buy rating on the shares. Q3 revenues were below…
Research Solutions price target lowered to $4 from $5 at Maxim
Maxim analyst Allen Klee lowered the firm’s price target on Research Solutions (RSSS) to $4 from $5 and keeps a Buy rating on the shares after its Q1 revenue fell…
Research Solutions reports Q3 EPS 3c, consensus 4c
Reports Q3 revenue $12.1M, consensus $12.37M. “We introduced a pair of new AI-based products in recent months, giving Article Galaxy and Scite users the ability to search, review and acquire…
Research Solutions Earnings Call Transcript: Q3 2026
Q3 FY26 saw improved EBITDA and net income, but revenue declined year-over-year due to B2B churn, despite strong new bookings and AI-driven product launches. Gross margin improved, and management expects continued EBITDA growth and stronger cash generation into Q4.
Research Solutions Earnings release: Q3 2026
Research Solutions released its Q3 2026 earnings on May 14, 2026, summarizing the period's financial results.
Research Solutions Quarterly report: Q3 2026
Research Solutions has published its Q3 2026 quarterly earnings report on May 14, 2026.
Research Solutions Reports Third Quarter Fiscal Year 2026 Results
Reports 8.5% Increase in ARR to $22.1 Million, Net Income of $860,000 and 14% Year-over-Year Growth in Adjusted EBITDA HENDERSON, Nev., May 14, 2026 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ: ...
Research Solutions to Announce Third Quarter Fiscal Year 2026 Results on Thursday, May 14, 2026
HENDERSON, Nev., May 6, 2026 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ: RSSS), the leading AI-powered research workflow platform, will hold a conference call to discuss its financial results f...
Research Solutions' Scite Launches Claude Connector For Citation-Backed Research
Expands Scite's AI Platform Footprint Alongside Its Existing ChatGPT App, Grounding Researchers' Answers In 250M+ Scientific Articles & Smart Citations Within Their Existing Tools HENDERSON, Nev., Apr...
Research Solutions Announces New Article Galaxy MCP, Giving AI Agents The Ability To Find, License, & Access Scientific Literature
Organizations Can Now Connect Their Existing Libraries, Entitlements, & Acquisition Workflows Directly To Broad AI-Powered Research Tools HENDERSON, Nev., April 7, 2026 /PRNewswire/ -- Research Soluti...
Research Solutions to Participate in the 38th Annual ROTH Conference
HENDERSON, Nev., March 19, 2026 (GLOBE NEWSWIRE) -- via IBN -- Research Solutions (NASDAQ: RSSS) today announces that members of its executive management team will be available for 1-on-1 and small gr...
Research Solutions Expands Into Africa With University Of Pretoria As First Partner
The Continent's Leading Research-Intensive University Signs A Three-Year Agreement with Research Solutions' AI Platform, Scite HENDERSON, Nev., March 12, 2026 /PRNewswire/ -- Research Solutions (NASDA...
Research Solutions Launches Scite MCP, Connecting ChatGPT, Claude, & Other AI Tools To Scientific Literature
Scite Platform Now Connects Directly To Leading AI Tools, Enabling Researchers To Get Evidence-Backed Answers Grounded In 250 Million+ Scientific Articles HENDERSON, Nev., Feb. 26, 2026 /PRNewswire/ -...
Research Solutions price target lowered to $5 from $6 at Maxim
Maxim lowered the firm’s price target on Research Solutions (RSSS) to $5 from $6 and keeps a Buy rating on the shares. The company’s revenue was below estimates and consensus…
Research Solutions Earnings Call Transcript: Q2 2026
Q2 2026 saw flat revenue but strong B2B ARR growth and margin expansion, offset by B2C softness and transaction declines from churned accounts. API and AI integration are driving larger, stickier contracts, while cost discipline and cash flow remain strong.
Research Solutions Quarterly report: Q2 2026
Research Solutions has published its Q2 2026 quarterly earnings report on February 12, 2026.
Research Solutions Earnings release: Q2 2026
Research Solutions released its Q2 2026 earnings on February 12, 2026, summarizing the period's financial results.
Research Solutions reports Q2 EPS 2c, consensus 3c
Reports Q2 revenue $11.8M, consensus $12.16M. “Our second quarter results reflect strong growth within our B2B Platforms business through forty-seven net new deployments in the quarter and Platforms c...
Research Solutions Reports Second Quarter Fiscal Year 2026 Results
Reports 14% Increase in ARR to $21.8 Million, Net Income of $547,000 and 36% Year-over-Year Growth in Adjusted EBITDA HENDERSON, Nev., Feb. 12, 2026 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ: R...
Research Solutions to Announce Second Quarter Fiscal Year 2026 Results on Thursday, February 12, 2026
HENDERSON, Nev., Jan. 29, 2026 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ: RSSS), the leading AI-powered research workflow platform, will hold a conference call to discuss its financial result...